147 related articles for article (PubMed ID: 1763231)
1. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
Bernardeschi P; Bonechi I
Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
[TBL] [Abstract][Full Text] [Related]
2. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic possibilities in the treatment of the myelodysplasia syndrome].
Bozóky G; Biliczki F
Orv Hetil; 1991 May; 132(19):1011-5. PubMed ID: 2027674
[TBL] [Abstract][Full Text] [Related]
4. [Factors influencing leukemic transformation in myelodysplastic syndrome].
Borbényi Z; Varga G; Bérczi M; Gurzó M
Orv Hetil; 1990 Jun; 131(23):1231-6, 1239-40. PubMed ID: 2199892
[TBL] [Abstract][Full Text] [Related]
5. [Course of refractory anemias. Study of 49 cases].
Najman A; Harousseau JL; Gorin NC; Duhamel G; André R
Ann Med Interne (Paris); 1974 Oct; 125(10):703-9. PubMed ID: 4532471
[No Abstract] [Full Text] [Related]
6. [Long-term myelodysplastic syndrome transformed into blastic leukemia].
Dimova R; Apostolov P; Popova L
Vutr Boles; 1988; 27(4):99-103. PubMed ID: 3213032
[TBL] [Abstract][Full Text] [Related]
7. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia.
Hiçsönmez G; Gümrük F; Cetin M; Ozbek N; Tuncer M; Gürsel T
Turk J Pediatr; 1995; 37(4):425-9. PubMed ID: 8560614
[TBL] [Abstract][Full Text] [Related]
8. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
10. [15 patients with myelodysplastic syndrome].
Dimova R; Apostolov P; Popova L
Vutr Boles; 1989; 28(3):96-100. PubMed ID: 2773468
[TBL] [Abstract][Full Text] [Related]
11. Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors.
Vandermolen L; Rice L; Rose MA; Lynch EC
Arch Intern Med; 1988 Mar; 148(3):653-6. PubMed ID: 3341866
[TBL] [Abstract][Full Text] [Related]
12. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
13. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
[TBL] [Abstract][Full Text] [Related]
14. French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique.
Cancer; 1987 Sep; 60(6):1385-94. PubMed ID: 3476180
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes: natural history and features of prognostic importance.
Mufti GJ; Galton DA
Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
[No Abstract] [Full Text] [Related]
16. [Clonal study of hematopoietic cells].
Jinnai I
Rinsho Ketsueki; 1995 Apr; 36(4):273-8. PubMed ID: 7783329
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
18. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
19. [Transient ring sideroblastosis in a human bone marrow allograft (author's transl)].
Rozmán C; Grañena A; Woessner S; Brugues R; Montserrat E; Hernández-Nieto L; Vives-Corrons JL
Sangre (Barc); 1977; 22(4):508-14. PubMed ID: 331518
[No Abstract] [Full Text] [Related]
20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]